Sickle Cell Disease Drug Market By Drug Type ( Antibiotics, Hydroxyurea, Pain-relieving medications ), By Mode of Administration ( Oral, Intravenous ), By Disease Type ( Sickle cell anemia, Sickle beta thalassemia, Sickle hemoglobin c disease ), By Distribution Channel ( Retail pharmacies, Hospital pharmacies, Online pharmacies ), Industry Trends, Estimation & Forecast, 2017 - 2025

CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. SICKLE CELL DISEASE DRUG MARKET OVERVIEW 2.1. SICKLE CELL DISEASE DRUG MARKET INTRODUCTION 2.2. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Sickle Cell Disease Drug Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL SICKLE CELL DISEASE DRUG MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Sickle Cell Disease Drug Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL SICKLE CELL DISEASE DRUG MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Sickle Cell Disease Drug Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRICE TREND, 2017-2025 2.6.1. Global Sickle Cell Disease Drug Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL SICKLE CELL DISEASE DRUG MARKET BY DRUG TYPE, 2017-2025 3.1. ANTIBIOTICS 3.2. PAIN-RELIEVING MEDICATIONS 3.3. HYDROXYUREA 3.4. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE BY DRUG TYPE, 2017-2025 3.4.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Share (%) By Drug type, 2017-2025 3.4.2. Antibiotics Market Revenue and Growth Rate, 2017-2025 3.4.3. Pain-relieving medications Market Revenue and Growth Rate, 2017-2025 3.4.4. Hydroxyurea Market Revenue and Growth Rate, 2017-2025 3.5. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION BY DRUG TYPE, 2017-2025 3.5.1. Global Sickle Cell Disease Drug Market Production (Volume) and Share (%) By Drug type, 2017-2025 3.5.2. Antibiotics Market Production and Growth Rate, 2017-2025 3.5.3. Pain-relieving medications Market Production and Growth Rate, 2017-2025 3.5.4. Hydroxyurea Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for mode of administration segment. CHAPTER 4. GLOBAL SICKLE CELL DISEASE DRUG MARKET BY DISEASE TYPE, 2017-2025 4.1. SICKLE CELL ANEMIA 4.2. SICKLE BETA THALASSEMIA 4.3. SICKLE HEMOGLOBIN C DISEASE 4.4. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE BY DISEASE TYPE, 2017-2025 4.4.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Share (%) By Disease type, 2017-2025 4.4.2. Sickle cell anemia Market Revenue and Growth Rate, 2017-2025 4.4.3. Sickle beta thalassemia Market Revenue and Growth Rate, 2017-2025 4.4.4. Sickle hemoglobin c disease Market Revenue and Growth Rate, 2017-2025 4.5. GLOBAL SICKLE CELL DISEASE DRUG MARKET CONSUMPTION BY DISEASE TYPE, 2017-2025 4.5.1. Global Sickle Cell Disease Drug Market Consumption (Volume) and share (%) By Disease type, 2017-2025 4.5.2. Sickle cell anemia Market Consumption and Growth Rate, 2017-2025 4.5.3. Sickle beta thalassemia Market Consumption and Growth Rate, 2017-2025 4.5.4. Sickle hemoglobin c disease Market Consumption and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for distributed channel segment. CHAPTER 5. GLOBAL SICKLE CELL DISEASE DRUG MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL SICKLE CELL DISEASE DRUG MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Sickle Cell Disease Drug Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL SICKLE CELL DISEASE DRUG MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Sickle Cell Disease Drug Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Sickle Cell Disease Drug Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL SICKLE CELL DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL SICKLE CELL DISEASE DRUG PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Sickle Cell Disease Drug Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL SICKLE CELL DISEASE DRUG REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Sickle Cell Disease Drug Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. SICKLE CELL DISEASE DRUG MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Sickle Cell Disease Drug Market Share (%) of Top 3 Manufacturers 8.3.2. Sickle Cell Disease Drug Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL SICKLE CELL DISEASE DRUG MANUFACTURERS ANALYSIS 9.1. ACCELERON PHARMA 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Sickle Cell Disease Drug Product Details 9.1.4. Acceleron Pharma Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.2. EPIDESTINY 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Sickle Cell Disease Drug Product Details 9.2.4. Epidestiny Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.3. ERRANT GENE THERAPEUTICS 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Sickle Cell Disease Drug Product Details 9.3.4. Errant Gene Therapeutics Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.4. GAMIDA CELL 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Sickle Cell Disease Drug Product Details 9.4.4. Gamida Cell Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.5. PFIZER INC. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Sickle Cell Disease Drug Product Details 9.5.4. Pfizer Inc. Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.6. GLOBAL BLOOD THERAPEUTICS 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Sickle Cell Disease Drug Product Details 9.6.4. Global Blood Therapeutics Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.7. HILLHURST BIOPHARMACEUTICALS 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Sickle Cell Disease Drug Product Details 9.7.4. Hillhurst Biopharmaceuticals Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.8. NOVARTIS 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Sickle Cell Disease Drug Product Details 9.8.4. Novartis Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.9. BLUEBIRD BIO, INC. 9.9.1. Business Overview 9.9.2. Company Basic Information 9.9.3. Sickle Cell Disease Drug Product Details 9.9.4. Bluebird bio, Inc. Sickle Cell Disease Drug Production, Revenue and Gross Margin 9.10. REGENACY PHARMACEUTICALS 9.10.1. Business Overview 9.10.2. Company Basic Information 9.10.3. Sickle Cell Disease Drug Product Details 9.10.4. Regenacy Pharmaceuticals Sickle Cell Disease Drug Production, Revenue and Gross Margin CHAPTER 10. SICKLE CELL DISEASE DRUG MARKET VALUE CHAIN ANALYSIS 10.1. SICKLE CELL DISEASE DRUG INDUSTRIAL CHAIN ANALYSIS 10.2. SICKLE CELL DISEASE DRUG KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. MARKETING CHANNEL 10.3.1. Direct Marketing 10.3.2. Indirect Marketing 10.3.3. Distributors/Traders 10.4. CONSUMER ANALYSIS 10.4.1. Consumer 1 10.4.2. Consumer 2 10.4.3. Consumer 3 10.4.4. Consumer 4